Profile of Low Density Lipoprotein Levels and Distribution of Hypertension Degrees in Hypertension Patients at the Internal Medicine Polyclinic of RSI Siti Rahmah Padang in 2024

Hypertension is one of the major health problems associated with an increased risk of cardiovascular disease. Low-density lipoprotein (LDL) is an important lipid profile parameter in assessing cardiovascular risk, making the evaluation of LDL levels in hypertensive patients essential for identifying associated risk factors. This study aimed to determine the profile of LDL levels and the distribution of hypertension degrees among hypertensive patients at the Internal Medicine Polyclinic of RSI Siti Rahmah Padang in 2024. This descriptive study employed a cross-sectional design using secondary data obtained from the medical records of 104 hypertensive patients who received outpatient care at the Internal Medicine Polyclinic of RSI Siti Rahmah Padang during 2024. The variables examined included age, gender, LDL levels, and degree of hypertension. Data were analyzed descriptively and presented as frequency distributions, percentages, means, and medians. Of the 104 patients, the largest age group was 45–60 years, comprising 54 patients (51.9%), while women accounted for the majority of participants, with 76 patients (73.1%). Regarding the degree of hypertension, 67 patients (64.4%) were classified as having prehypertension, 31 (29.8%) had first-degree hypertension, and 6 (5.8%) had second-degree hypertension. In terms of LDL levels, 57 patients (54.8%) had normal LDL levels, whereas 47 (45.2%) had elevated LDL levels. The mean LDL level was 130.57 ± 38.16 mg/dL, with a median of 127.5 mg/dL and a range of 30–243 mg/dL. In conclusion, the hypertensive patients treated at the Internal Medicine Polyclinic of RSI Siti Rahmah Padang in 2024 were predominantly women and individuals aged 45–60 years. Most patients were classified as having prehypertension and had normal LDL levels, although the proportion of patients with elevated LDL levels remained substantial. These findings highlight the importance of routine lipid profile monitoring as part of comprehensive cardiovascular risk assessment in hypertensive patients.